Results 151 to 160 of about 62,187 (355)

External cephalic version outcomes with tocolysis and sedation: A 10‐year retrospective cohort study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To evaluate the effectiveness and safety of external cephalic version (ECV) performed with tocolysis and sedation or spinal anesthesia, and to identify predictors of ECV success, complications, and delivery outcomes after successful ECV. Methods This 10‐year cohort study included 990 pregnant women with term non‐cephalic presentation
Javier Sánchez‐Romero, Rosa María Gallego‐Pozuelo, José Eliseo Blanco‐Carnero, Javier Herrera‐Giménez, Fernando Araico‐Rodríguez, Alberto Rafael Guijarro‐Campillo, Aníbal Nieto‐Díaz, Catalina de Paco‐Matallana   +7 more
wiley   +1 more source

Amino acid-responsive Crohn's disease: a case study

Clinical and Experimental Gastroenterology, 2010
Alvin Stein1, Marty Hinz2, Thomas Uncini31Stein Orthopedic Associates, Plantation, FL, USA; 2Clinical Research, NeuroResearch Clinics Inc., Cape Coral, FL, USA; 3Laboratory, Fairview Regional Medical Center-Mesabi, Hibbing, MN, USAPurpose: This paper ...
Alvin Stein, Marty Hinz, Thomas Uncini
doaj  

Crohn Disease [PDF]

JAMA, 2008
openaire   +2 more sources

Application of Artificial Intelligence in Clinical Microbiology: From Research to Practice

iLABMED, EarlyView.
This paper reviews the application of AI in clinical microbiology practice at home and abroad, including rapid pathogen identification, accurate characterization of microbial resistance patterns, optimization of laboratory workflows, and public health interventions.
Ting Ding, Yi‐Wei Tang, Xiaoke Hao
wiley   +1 more source

A Dual Action of Everolimus in Ulcerative Colitis: Blocking CLEC4E‐Driven Inflammation and Remodeling the Gut Microbiota‐Metabolite Axis

iMetaMed, EarlyView.
Graphical abstract of the major mechanisms of Everolimus in ulcerative colitis: Everolimus, a selective mTORC1 inhibitor, protects against ulcerative colitis through a dual mechanism. First, Eve directly suppresses CLEC4E/Syk/NF‐κB signaling, thereby reducing pro‐inflammatory cytokine production and preserving intestinal barrier integrity.
Jing Chen, Min Li, Wenyan Sun, Yuyun Chen, Yu Sheng, Cuihua Lu, Zhaoxiu Liu   +6 more
wiley   +1 more source

Orofacial granulomatosis (OFG) : sjúkdómstilfelli [PDF]

, 2007
Neðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/OpenMig langar til þess að kynna fyrir ykkur frekar sjaldgæfan sjúkdóm, sem nýtur þrátt fyrir það, töluverðar athygli meðal lækna og tannlækna þar sem tíðnin ...
Helgi Hansson
core  

Crohn's Disease [PDF]

Postgraduate Medical Journal, 1949
openaire   +3 more sources

Clinical and Biochemical Factors Associated With Infliximab Pharmacokinetics in Adult Patients With Inflammatory Bowel Disease

The Journal of Clinical Pharmacology, EarlyView.
Abstract Many patients with inflammatory bowel disease (IBD) do not adequately respond to infliximab, potentially due to individual differences in pharmacokinetics (PK). This study aimed to identify clinical and biochemical variables associated with infliximab PK.
Ilse A. Pool, Ilse Volkerink, Mirthe Stavast, Jos G. W. Kosterink, Gerard Dijkstra, Paola Mian, Arno R. Bourgonje   +6 more
wiley   +1 more source

Perianal and Luminal Relapse Following Perianal Surgical Intervention in Crohn’s Disease

, 2021
Francis Deng, Peng Xia, Zufang Wu, H Zhou, X Wang   +4 more
openalex   +1 more source

Accuracy of Bowel Ultrasound for Detecting Inflammatory Bowel Disease at a Tertiary Hospital in Central South Africa

Journal of Clinical Ultrasound, EarlyView.
Bowel wall thickness, as measured by bowel ultrasound, demonstrates high diagnostic accuracy in evaluating patients with suspected inflammatory bowel disease (IBD). When combined with other bowel ultrasound parameters, this non‐invasive tool can serve as an effective screening method to accelerate IBD diagnosis.
Amanda Hendricks, Henra Muller
wiley   +1 more source